Initial 3-year results of first human use of an in-body tissue-engineered autologous “Biotube” vascular graft for hemodialysis
Authors:
Open Access
- 6 June 2019
- journal article
- case report
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 21 (1) , 110-115
Abstract
This study presents the initial 3-year results of the first in-human study of internal shunt restoration using completely autologous vascular grafts, “Biotubes,” based on in-body tissue architecture. Biotubes (diameter, 6 mm; length, 7 cm) were prepared as autologous collagenous tubular tissues with approximately 0.5 mm wall thickness by embedding molds (two per patient), assembled with a silicone rod and a stainless steel pipe with many slits, into the patients’ abdominal subcutaneous tissue for 2 months. Two female patients with end-stage renal disease were undergoing hemodialysis with a high probability of failure due to repeated stenosis every few months at the venous outflow regions over 1.5 years. Biotubes formed in both patients and were bypassed over the venous stenosis region of the arteriovenous shunt. After bypass with Biotubes without living cells, palpable thrill and typical turbulent flow pattern were observed by pulsed-wave Doppler. Follow-up angiography showed no signs of dilation or stenosis after implantation, and puncture could be performed easily without graft damage. In both cases, stenosis of Biotubes occurred after 3–4 months. In the first case, percutaneous transluminal angioplasty was not required for over 2 years after implantation even after the development of Biotube stenosis. In the second case, stenosis at the proximal anastomotic site of the Biotube became prominent, and percutaneous transluminal angioplasty was needed 7 months after implantation and then repeated at up to 2 years. This was the first human study successfully supporting the concept of internal shunt restoration for hemodialysis using an autologous Biotube.Keywords
Funding Information
- Japan Science and Technology Agency
This publication has 20 references indexed in Scilit:
- Long-term outcomes of bovine pericardial patch angioplasty for recurrent stenosis in vascular access: A UK single-centre experienceThe Journal of Vascular Access, 2018
- The Tissue-Engineered Vascular Graft—Past, Present, and FutureTissue Engineering Part B: Reviews, 2015
- Impact of pericardium bovine patch (Tutomesh®) on incisional hernia treatment in contaminated or potentially contaminated fields: retrospective comparative studyHernia, 2014
- Patency Rates of the Arteriovenous Fistula for Hemodialysis: A Systematic Review and Meta-analysisAmerican Journal of Kidney Diseases, 2014
- Short- and mid-term results of xenograft–bovine pericardial patch in the repair of intracardiac defects: final results of a single-centre studyCardiology in the Young, 2013
- Future of vascular surgery is in the officeJournal of Vascular Surgery, 2010
- The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis accessJournal of Vascular Surgery, 2008
- Aortic valve replacement with the Mitroflow pericardial bioprosthesis: Durability results up to 21 yearsThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Human tissue-engineered blood vessels for adult arterial revascularizationNature Medicine, 2006
- Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cellsThe Journal of Thoracic and Cardiovascular Surgery, 2005